Rachel is Chief Operating Officer of Oviva Therapeutics. Before joining Oviva, Rachel led the spin outs and operations of healthcare technology and biotech businesses for Roivant Sciences. Rachel has a background in investment management and was most recently Vice President of the Alternative Investments and Manager Selection business within Goldman Sachs. Rachel has a B.S. from Cornell University. Rachel lives in Connecticut with her husband, two sons, and expected baby girl.
